ArticleHigh blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension2026
A Real-Life Survey on the Management of Arterial Hypertension in Italy.
Article in High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
introductionThe use of epidemiological surveys might contribute to identify ineffective clinical behaviors and to improve them with educational interventions.
aimIn the present survey, we evaluated the clinical attitudes for the management of patients with hypertension, in a sample of physicians in Italy who were included in an educational program in 2023.
methodsData from a total of 995 hypertensives (mean age 64.8 ± 13.3 years; 58.4% men) were reported in the survey. Complete data on antihypertensive treatment use and achievement of blood pressure (BP) goals at follow-up were available for only 494 individuals, whose data were therefore analyzed and compared with baseline.
resultsAt baseline, 381 patients received BP-lowering treatment, 146 (31.6%) were treated with monotherapy, 129 (26.1%) with free dose combinations and 106 (21.4%) with single-pill FDCs. BP values < 140/80 mmHg and < 130/80 mmHg were detected in 70 (14.2%) and 23 (4.6%) subjects, respectively. At follow-up evaluation, the number of treated patients rise to 462, 44 receiving monotherapy, 35 free dose combinations and 383 single-pill FDCs (p < 0.05 compared to baseline). A significant improvement of BP control was achieved, and BP values < 140/80 mmHg and < 130/80 mmHg were recorded in 470 (95.1%) and 383 (77.5%) individuals, respectively (p < 0.05 compared to baseline).
conclusionsThe survey identified a high prevalence of uncontrolled hypertension in the examined sample with a low use of FDCs also by specialist physicians qualified to treat high BP. After the attendance to an educational program, the prescription of FDCs significantly raised in parallel with the increase in the proportion of patients who reached recommended BP targets.
Indexed as
Identifiers
41266860What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.